← FDA DRUG APPROVALS

FDA NDA · NDA020506

TIAMATE

Sponsor: MERCK

APPLICATION
NDA020506
TYPE
NDA
ORIGINAL APPROVAL
1996-10-04
LATEST ACTION
1996-10-04
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

TIAMATEDiscontinued
DILTIAZEM MALATE EQ 240MG HYDROCHLORIDE · TABLET, EXTENDED RELEASE · ORAL
TIAMATEDiscontinued
DILTIAZEM MALATE EQ 120MG HYDROCHLORIDE · TABLET, EXTENDED RELEASE · ORAL
TIAMATEDiscontinued
DILTIAZEM MALATE EQ 180MG HYDROCHLORIDE · TABLET, EXTENDED RELEASE · ORAL

Approval history

1996-10-04Type 2 - New Active Ingredient · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →